| Melissa M Bacon, DO | |
|
113 Mcrae Pt, Madison, MS 39110-6579 | |
| (507) 250-7030 | |
| Not Available |
| Full Name | Melissa M Bacon |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 113 Mcrae Pt, Madison, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356458012 | NPI | - | NPPES |
| 09336744 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 24598 (Mississippi) | Primary |
| Entity Name | State Of Mississippi - University Of Mississippi Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154317527 PECOS PAC ID: 1850293036 Enrollment ID: O20090414000575 |
News Archive
The Annual Report to the Nation on the Status of Cancer, 1975-2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate.
We experience the world through our senses, a constant torrent of sights, sounds, smells, and more. Our brains take these signals and process them, giving rise to our individual perceptions of the world. But sometimes our senses play tricks on us, notably in the case of perceptual illusions.
Is it possible to convert a patient's own skin cells into functioning nerve cells? Or insert healthy genes to reprogram the cells of a damaged brain? Stem cell researcher Malin Parmar at Lund University in Sweden is studying these types of issues, in close collaboration with clinical researchers.
A team of Canadian physicians and researchers is believed to be the first in the world to have used gene therapy to treat a patient with Fabry disease, a rare inherited enzyme deficiency that can damage major organs and shorten lifespan.
Biostar Pharmaceuticals, Inc., a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced that the Company was approved by NASDAQ to list its common stock on the NASDAQ Global Market. The Company's listing application was reviewed and approved by NASDAQ's Listing Qualifications Department for compliance with all of NASDAQ's standards.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa M Bacon, DO 113 Mcrae Pt, Madison, MS 39110-6579 Ph: (507) 250-7030 | Melissa M Bacon, DO 113 Mcrae Pt, Madison, MS 39110-6579 Ph: (507) 250-7030 |
News Archive
The Annual Report to the Nation on the Status of Cancer, 1975-2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate.
We experience the world through our senses, a constant torrent of sights, sounds, smells, and more. Our brains take these signals and process them, giving rise to our individual perceptions of the world. But sometimes our senses play tricks on us, notably in the case of perceptual illusions.
Is it possible to convert a patient's own skin cells into functioning nerve cells? Or insert healthy genes to reprogram the cells of a damaged brain? Stem cell researcher Malin Parmar at Lund University in Sweden is studying these types of issues, in close collaboration with clinical researchers.
A team of Canadian physicians and researchers is believed to be the first in the world to have used gene therapy to treat a patient with Fabry disease, a rare inherited enzyme deficiency that can damage major organs and shorten lifespan.
Biostar Pharmaceuticals, Inc., a Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules, and a variety of pharmaceutical products, today announced that the Company was approved by NASDAQ to list its common stock on the NASDAQ Global Market. The Company's listing application was reviewed and approved by NASDAQ's Listing Qualifications Department for compliance with all of NASDAQ's standards.
› Verified 7 days ago
Dr. Leslie F Mason, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 115 Fountains Blvd, Suite A, Madison, MS 39110 Phone: 601-853-0100 Fax: 601-853-3999 | |
Dr. Erika Love Tanner, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 115 Fountains Blvd, Suite A, Madison, MS 39110 Phone: 601-853-0100 Fax: 601-853-3999 |